Application | Comment | Organism |
---|---|---|
medicine | the enzyme constitutes an important biological target for the most popular class of antifungals | Candida albicans SC5314 |
pharmacology | the enzyme constitutes an important biological target for the most popular class of antifungals | Candida albicans SC5314 |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-(methylamino)thiazol-4(5H)-one | - |
Candida albicans SC5314 | |
2-(naphthalen-1-ylamino)thiazol-4(5H)-one | - |
Candida albicans SC5314 | |
5-(2,4-dichlorobenzylidene)-2-(naphthalen-1-ylamino)thiazol-4(5H)-one | - |
Candida albicans SC5314 | |
5-(4-nitrobenzylidene)-2-(phenylamino)thiazol-4(5H)-one | - |
Candida albicans SC5314 | |
fluconazole | - |
Candida albicans SC5314 | |
additional information | the enzyme constitutes an important biological target for the most popular class of antifungals. Inhibition of lanosterol 14alpha-demethylase leads to accumulation of 14-a-methylsterols on the fungal surface and alteration of the permeability and rigidity of the plasma membrane, which results in arrest of fungal growth. Because this enzyme is found in all eukaryotes (including humans) and because the azoles interact also with other cytochrome P450 dependent enzymes (CYP3A4), a selective inhibition towards the fungal CYP51A1 is essential for an increased therapeutic index | Candida albicans SC5314 |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Candida albicans SC5314 | P10613 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
CYP51A1 | - |
Candida albicans SC5314 |
lanosterol 14alpha-demethylase | - |
Candida albicans SC5314 |
General Information | Comment | Organism |
---|---|---|
metabolism | key enzyme in the synthesis of ergosterol, an essential component of the fungal cell membrane | Candida albicans SC5314 |
physiological function | key enzyme in the synthesis of ergosterol, an essential component of the fungal cell membrane | Candida albicans SC5314 |